Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Business Week’s Gene Marcial’s New Stock Picks

CEO Blogger (October 28th, 2008) Writes:

Gene Marcial, Inside Wall Street Guru at Business Week, picked the following stocks for the 11/3 issue; his picks can be tracked at:

http://trackthepros.com/stocks/category/404

Restaurants aren’t appealing buys in these times of economic stress, but Yum! Brands (YUM) looks appetizing, nonetheless. The world’s largest stable of restaurants owns and operates such fast-food chains as KFC, Pizza Hut, and Taco Bell in over 100 countries. Yum is a standout because not only is it seeing higher sales and earnings but it’s also reinvigorating U.S. sales with healthier food, such as fish, veggies, and grilled chicken.

The key drivers of Yum’s growth and profitability, though, are China and other foreign markets, which account for 50% of sales, says Rick Carucci, Yum’s CFO. “Yum is a great way to gain exposure to China’s booming economy and the other fast-growing international markets, while investing in the only stable segment of the restaurant industry,”

...

Æterna Zentaris Blazes A New Frontier

Mike Havrilla (July 6th, 2007) Writes:

A good balance sheet and a couple of of late-stage hormone therapy products underlie recently appointed CEO Dr. David Mazzo’s enthusiasm for the future prospects of the 16-year-old, Quebec-based biopharmaceutical firm Æterna Zentaris

Tags for this Post:
Abbott Lab, AEterna Zentaris, American Urological Association, Astrazeneca, benign prostatic hyperplasia, Biopharmaceutical, Biopharmaceuticals, Biotech, biotech, Breast Cancer, Canada, cancer, Cancers, Chemicals, Chemotherapy, cutaneous leishmaniasis, David Mazzo, endometriosis, Europe, Flomax, hormone deficiency, hormone therapy products, India, Japan, late-stage hormone therapy products, Lung Cancer, Lupron Depot, Lymphoma, marketed product, marketed products, multiple myeloma, Nippon Kayaku, North America, nutraceuticals, obesity, parasitic disease, Prostate Cancer, Quebec, Richard Lewis Communications, sarcoma, Shionogi, Solvay, Solvay Pharmaceuticals, therapy for multiple cancer, treatment of benign prostatic hyperplasia, treatment of lower urinary tract symptoms, treatment of obesity, treatment of prostate cancer, tumors, United States, USD, Æterna Zentaris

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.